Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Wide variability in the stability of Pd6Lx-type coordination cages

Jean de Montmollin , Farzaneh Fadaei-Tirani and Kay Severin *
Institut des Sciences et Ingénierie Chimiques, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland. E-mail: kay.severin@epfl.ch

Received 16th September 2025 , Accepted 2nd October 2025

First published on 8th October 2025


Abstract

The relative stability of hexanuclear Pd-based coordination cages has been investigated. For this purpose, we have synthesized eight cages of type [Pd6L12]12+ or [Pd6L8]12+. Six of these cages have been described before, and two are reported here for the first time, including crystallographic analyses. The stability of the cages was investigated by subjecting cage solutions in DMSO-d6 or CD3CN to different amounts of pyridine. The cage degradation was monitored by 1H NMR. Our findings reveal significant variability in cage stability. The relative thermodynamic stability of the cages varies by nearly two orders of magnitude and the kinetic stability by more than four orders of magnitude. The stability of the cages is primarily governed by the nature of the donor group, with denticity playing a subordinate role. The high kinetic stability conferred by imidazole-based ligands provided access to a rare octanuclear cage of the type [Pd8L16]16+, featuring a square antiprismatic geometry.


Introduction

Coordination cages based on [Pd(N-donor)4]2+ links represent a well-established class of metallosupramolecular architectures.1 Work in this area has primarily focused on exploring the structural diversity of these assemblies. Cages with a wide range of nuclearities have been reported, spanning from simple [Pd2L4]4+-type cages2 to giant [Pd48L96]96+ nanospheres.3 Moreover, intricate architectures such as interlocked cages4 and heteroleptic assemblies5 were uncovered. The self-assembly of these cages typically relies on the predictable square-planar coordination geometry of PdII centers and the careful design of N-donor ligands, which govern the size, shape, and symmetry of the resulting supramolecular architectures.1,6

Alongside structural investigations, significant efforts have been devoted to exploring the functional properties of Pd-based cages, including their host–guest chemistry, catalytic activity, photophysical properties, and potential for molecular separation, extraction, and delivery.1,7–9 The use of Pd cages in materials science has also been reported.10

A potential Achilles heel for applications of Pd-based cages is their limited chemical stability. Cleavage of the [Pd(N-donor)4]2+ crosslinks was observed for a range of simple anions such as chloride,11 phosphate,12 or acetate.13 Biomolecules such as amino acids11b–d or glutathione14 can likewise act as competitive ligands, resulting in cage disassembly. Pd cages also show limited stability under acidic conditions.15

As expected, the strength of the coordination bond between Pd2+ and the respective N-donor ligand is a crucial factor for the stability of [Pd(N-donor)4]2+-based cages.11c,d,15 Imidazole ligands are typically stronger donors than simple pyridine ligands.16 Accordingly, cages based on polyimidazole ligands are expected to be more stable than cages based on polypyridyl ligands. Experimentally, this point was corroborated by ligand exchange studies.17 4-Dimethylaminopyridine (DMAP) is a potent ligand for Pd2+, and several studies have shown that Pd-based cages are quantitatively destroyed upon addition of DMAP.11f,18

While the importance of the strength of the N-donor is well established, other potential factors influencing the stability of Pd-based cages are less well understood. For instance, cages constructed from tritopic ligands should be favored over those based on ditopic ligands from an entropy point of view (assuming identical nuclearity). Regarding the relative kinetic stability of Pd-based cages, there is only limited information available, with previous studies focusing largely on simple dinuclear [Pd2L4]4+ cages.11b–d

For the present study, we have compared the thermodynamic and kinetic stability of eight hexanuclear Pd cages. The cages have a similar octahedral geometry, but they feature different bridging ligands, including di- and tritopic N-donors, and different types of donor groups. Our investigations have revealed a wide variability in the relative stability of the cages. Notably, the kinetic stability was found to differ by more than four orders of magnitude. We have exploited the high kinetic stability, which is provided by imidazole-based ligands, to access a rare octanuclear cage of type [Pd8L16]16+ with a square antiprismatic structure.

Results and discussion

For our study, we have employed the di- and tritopic ligands L1–L8 (Fig. 1). The ligands feature N-substituted imidazoles (L1–L3) or substituted pyridines (L4–L8) as donor groups. In addition to the pyridyl group, ligand L5 also has a 1,2,4-triazole donor group. To the best of our knowledge, the thiophenylene-bridged ligand L3 has so far not been used for the construction of Pd-based cages. Its synthesis was achieved by Ullman coupling (for details, see the SI).
image file: d5dt02223a-f1.tif
Fig. 1 Structures of the ligands L1–L8.

The ligands L1–L8 were combined with Pd(NO3)2 or [Pd(CH3CN)4](BF4)2 to give the hexanuclear Pd cages C1–C8 after thermal equilibration in either DMSO-d6 or CD3CN (Scheme 1). The choice of the Pd precursor and the solvent was largely dictated by the solubility of the final assembly.


image file: d5dt02223a-s1.tif
Scheme 1 Synthesis of the hexanuclear coordination cages C1–C8.

The known cages C4,19C7[thin space (1/6-em)]19 and C8[thin space (1/6-em)]20 were isolated according to literature procedure. Cage C2 was reported to form by combining L2 with Pd(NO3)2 in DMSO.21 Instead, we synthesized C2 in CD3CN with [Pd(CH3CN)4](BF4)2 and purified it by precipitation with ethyl acetate. Cage solutions of C5 and C6 in CD3CN were obtained without additional purification steps following literature procedures.22,23

The cages C1 and C3 have not been reported before. The commercially available ligand L1 (4 equiv.) was combined with [Pd(CH3CN)4](BF4)2 (3 equiv.) in CD3CN. After heating the mixture for 20 h to 80 °C, the 1H NMR spectrum showed broad, ill-defined peaks. However, when the solution was heated to 150 °C for 20 h using a microwave reactor, the 1H NMR spectrum indicated the formation of a defined assembly with high apparent symmetry (see Fig. S4). The high-resolution mass spectrum showed prominent peaks for a hexanuclear complex of the formula [[Pd6(L1)8](BF4)n](12−n)+ (n = 2–8) (see Fig. S10). Single crystals of cage C1 were grown by slow vapor diffusion of ethyl acetate and diethyl ether into a solution of C1 in CD3CN. Single-crystal XRD analysis of C1 showed the expected octahedral arrangement of the six Pd2+ ions (Fig. 2). With a maximum Pd⋯Pd distance of 25.4(2) Å, cage C1 is the second largest cage in our cohort, only topped by C4 (Pd⋯Pd = 25.6 Å). Four BF4 ions in crystalline C1 are found in the cage cavity, two at the surface between ligands, and six outside the cage.


image file: d5dt02223a-f2.tif
Fig. 2 Molecular structures of the cages C1–C8 in the solid state, as determined by single-crystal XRD. Hydrogen atoms and counter anions are omitted. Color coding: Pd dark green, C grey, N blue, O red. The data for the known cages C2, C4, C5, C6, and C8 were taken from the literature.

Cage C3 was obtained by combining L3 (2 equiv.) with [Pd(CH3CN)4](BF4)2 (1 equiv.) in CD3CN. After heating to 80 °C for 20 hours, C3 was formed in nearly quantitative yield as shown by 1H NMR spectroscopy (Fig. S13). The formation of a hexanuclear cage was confirmed by mass spectrometry: dominant peaks for a complex of the formula [[Pd6(L3)12](BF4)n](12−n)+ (n = 4–9) were observed (Fig. S19). Single crystals of cage C3 were grown by slow vapor diffusion of diisopropyl ether into a solution of C3 in CD3CN. Single-crystal XRD analysis of C3 showed the expected octahedral arrangement of the six Pd2+ ions (Fig. 2). The maximum Pd⋯Pd distance of C3 is 16.6(1) Å, which makes C3 the smallest cage that we have used in our study. Four BF4 ions in crystalline C3 are found inside the cage, and eight could be localized outside. In solution, there is apparently a rapid exchange between the BF4 ions as only one 19F NMR signal was observed.

It is interesting to note that the ligands L2 and L3 give both octahedral coordination cages, despite the fact that the two ligands have distinct spacers (phenylene vs. thiophenylene). However, the ligand bent angle, as defined by the angle between the coordinate vectors of the two N-donor groups, is not fixed in these ligands (the bent angle changes upon rotation around the spacer–imidazole bond). In C3, the central thiophenylene spacers are rotated out of plane relative to the coplanar imidazole moieties, thereby increasing the bent angle and enabling an octahedral arrangement.

The synthesis of cage C7 was reported by Crowley and co-workers.19 They were unable to obtain XRD-quality single crystals, and molecular modeling was used to derive structural information. We could obtain single crystals of C7 in a similar fashion as for C3, i.e. by slow vapor diffusion of diisopropyl ether into a solution of C7 in CD3CN. Unlike in the molecular model reported by Crowley et al.,19 the pyridyl donor groups in crystalline C7 adopt a propeller-like conformation around each palladium center. The six Pd(pyridyl)4 complexes in C7 show the same helicity, giving rise to pairs of enantiomeric cages in the solid state (see Fig. S58).

To quantify the relative stability of the cages C1–C8, we introduce DPy50 (‘Destructive Pyridine’) values. In analogy to the commonly used LD50 values to quantify the toxicity of compounds, the DPy50 value gives the amount of pyridine (in cage equivalents) at which 50% of the cage is destroyed at thermodynamic equilibrium, given a uniform initial cage concentration.

The DPy50 values for the cages C1–C8 were determined as follows: solutions of the cages (∼0.33 mM) were subjected to increasing amounts of pyridine-d5 (Scheme 2). Either DMSO-d6 or CD3CN was used as the solvent, with the choice being influenced by the solubility of the respective cage. After each pyridine addition, the NMR tube was heated for 2 h at 80 °C. This thermal treatment was found to be sufficient to establish the new thermodynamic equilibrium (see Fig. S27). Subsequently, a 1H NMR spectrum was recorded, and the decrease in cage concentration was quantified using durene as an internal standard.


image file: d5dt02223a-s2.tif
Scheme 2 Destruction of the cages C1–C8 with pyridine-d5.

The NMR spectra recorded after the addition of pyridine-d5 were remarkably ‘clean’. The major signals in the spectra could be assigned to those of the free ligands and of the remaining cages. The Pd2+ ions from the destroyed cages were captured in the form of [Pd(pyridine-d5)4]2+, as confirmed by mass spectrometry. Only minor amounts of other, unidentified species were observed. As a representative example, selected 1H NMR spectra for the decomposition of C1 are depicted in Fig. 3.


image file: d5dt02223a-f3.tif
Fig. 3 Aromatic parts of the 1H NMR spectra (CD3CN, 400 MHz) of C1, C1 after equilibration with 600 eq. of pyridine-d5, C1 after equilibration with 840 eq. of pyridine-d5, and the ‘free’ ligand L1 (from the top to the bottom).

From the NMR spectra, we were able to derive the cage concentrations at a given pyridine-d5 concentration. The DPy50 values were obtained from the intersection between the linear interpolation of the data points and the horizontal line corresponding to 50% cage decomposition (Fig. 4a). Since all cages are converted largely into the same complex, [Pd(pyridine-d5)4]2+, the DPy50 values serve as a proxy for the relative thermodynamic stability of the cages.


image file: d5dt02223a-f4.tif
Fig. 4 Destruction of the cages C1–C8 upon addition of increasing amounts of pyridine-d5 (a). The resulting DPy50 values for experiments performed in CD3CN (b) or in DMSO-d6 (c).

In CD3CN, both the most stable cage, C1 (DPy50 = 624), and the least stable cage, C7 (DPy50 = 10), are based on tritopic ligands (Fig. 4b). Apparently, the nature of the donor group is more important than ligand denticity. The high stability of the cages C2 (DPy50 = 534) and C3 (DPy50 = 165) with ligands featuring strong imidazole donors further underlines this point. The drop in stability between C2 and C3 can be attributed, at least in part, to the electronic effect of the spacer group. Calculations show that 1-phenylimidazole is slightly more basic than 1-thiophenylimidazole (for details, see Fig. S26). Accordingly, it is expected that L2 is a better donor than L3.

For the values determined in DMSO-d6 (Fig. 4c), a pronounced difference in the stability of the [Pd6L8]12+ cages C4 (DPy50 = 78) and C7 (DPy50 = 7.5) was observed. As in the case of C2 and C3, we attribute this difference to the electronic effect of the spacer (alkynyl vs. phenylene). For cage C7, we were able to perform experiments in both CD3CN and DMSO-d6, yielding similar values in both solvents.

The lowest thermodynamic stability of all cages was found for C8. The poor stability is likely linked to the low basicity of the pyridine donors in this ligand (for details, see Fig. S26).

To evaluate the kinetic stability of the cages C1–C8, we added a large excess of pyridine-d5 to solutions of the cages in CD3CN or DMSO-d6 (∼0.33 mM). The cage degradation with time under these pseudo first-order kinetics conditions was then monitored by 1H NMR spectroscopy. The amount of pyridine-d5 was chosen so that cage disassembly occurred on the minute-to-hour time scale.

It quickly became apparent that we could not use a uniform amount of pyridine-d5 for these experiments because the kinetic stability of the cages varied too much. Therefore, we decided to evaluate the relative stability of the cages in pairs. For a given pair, a fixed amount of pyridine-d5 was employed, and the half-lives (t1/2) of the decomposition reactions were determined by linear regression. For the cage pair C1/C2, for example, 3000 equivalents of pyridine-d5 were used, leading to the nearly complete disassembly of both cages within 20–30 min (Fig. 5). From the time-dependent NMR measurements, we were able to derive t1/2 values of 3.3 min (C1) and 10 min (C2).


image file: d5dt02223a-f5.tif
Fig. 5 Time course for the disassembly of the cages C1 and C2 after the addition of 3000 equivalents of pyridine-d5 (left) and the corresponding linear regression assuming first-order kinetics (right).

For experiments in CD3CN, we have analyzed the relative kinetic stability of the cage pairs C7/C6 (120 eq. pyridine), C6/C5 (240 eq. pyridine), C5/C3 (1200 eq. pyridine), C3/C1 (1200 eq. pyridine), and C2/C1 (3000 eq. pyridine) (Fig. 6a). For the comparison of C3 with C5, we observed the complete destruction of C5 within the time required to record the first 1H NMR spectrum (<1 min). Although lowering the pyridine-d5 concentration slowed the disassembly of C5, it also disrupted the pseudo-first-order kinetics for C3. Therefore, we performed a standard kinetic analysis for C3 with 1200 equivalents of pyridine-d5 (t1/2 = 15 min), and we estimated the half-life of C5 to be 0.3 min or shorter.


image file: d5dt02223a-f6.tif
Fig. 6 Half-lives of the decomposition reaction of the cages C1, C2, C3, C5, C6, and C7 in CD3CN upon addition of variable amounts of pyridine-d5 (a), and the relative kinetic stability of the cages (b).

By analyzing these cage pairs, we were able to rank the cages in terms of kinetic stability and express their stability relative to that of C7, which exhibited the lowest stability. We estimate that C2 is at least 16[thin space (1/6-em)]000 times more stable than C7 (Fig. 6b). It should be noted, however, that these values are approximate, as error accumulates with each multiplication step.

As in the thermodynamic analysis, the kinetic stability of the cages C4 and C8 was investigated in DMSO-d6, due to their limited solubility in CD3CN. Cage C7, which is soluble in both solvents, was included for comparison. The cages were analyzed again in pairs, with 120 equivalents of pyridine-d5 used for C7/C8, and 600 equivalents of pyridine-d5 used for C4/C8 (Fig. 7a). The results showed that C8 is 11 times more stable than C7, and that C4 is 17 times more stable than C8 (Fig. 7b).


image file: d5dt02223a-f7.tif
Fig. 7 Half-lives of the decomposition reaction of the cages C4, C7, and C8 in DMSO-d6 upon addition of 120 or 600 equivalents of pyridine-d5 (a), and the relative kinetic stability of the cages (b).

Since cage C7 was studied in both, CD3CN and DMSO-d6, we were able to evaluate the solvent effect on the kinetic stability. The decay of C7 was found to be approximately twice as fast in CD3CN (t1/2 = 3.8 min) when compared to DMSO-d6 (t1/2 = 8.9 min).

Overall, the ranking of the cages in terms of kinetic stability (Fig. 6 and 7) aligns well with their relative thermodynamic stability (Fig. 4). In CD3CN, only the ranking of the cages C1 and C2 is reversed, whereas in DMSO-d6, the ranking of the cages C7 and C8 is inverted. However, the differences in these cases are not pronounced. In terms of stability, the imidazole-based palladium cages C1–C3 stand out, surpassing the other five cages by a large margin.

In the following, we show that the kinetic stability of assemblies with the imidazole ligand L2 can be used to access a rare [Pd8L16]16+-type cage. When trying to synthesize cage C2 in deuterated nitromethane (80 °C, 20 h) instead of CD3CN, we noted the presence of side products (Fig. 8a). The mass spectrum of the reaction mixture indicated that the larger cages [Pd8(L2)16]16+ and [Pd9(L2)18]18+ had formed along with the expected hexanuclear cage [Pd6(L2)12]12+ (Fig. 8b).


image file: d5dt02223a-f8.tif
Fig. 8 (a) The reaction of L2 with [Pd(CH3CN)4](BF4)2 in CD3NO2 gives a mixture of three cages. (b) High-resolution ESI mass spectrum of the reaction mixture. (c) Part of the 1H NMR spectrum of the reaction mixture (top) and after depletion of [Pd6(L2)12]12+ by precipitation with ethyl acetate (bottom). The signals originate from the proton circled in red.

Octanuclear cages of type [Pd8L16]16+ are expected to display D4d symmetry, with a two-fold splitting of the NMR signals for the ligand.24 Cages of type [Pd9L18]18+ should show D3h symmetry, with three sets of NMR signals for the donor groups.24 Based on these symmetry considerations, we were able to deduce that the larger cages [Pd8(L2)16]16+ and [Pd9(L2)18]18+ had formed in 24% and 18%, respectively (Fig. 8a and c).

For Pd-based cages, the isolation of side products is often complicated by the dynamic behavior of these assemblies, which are prone to structural rearrangements. This difficulty is illustrated by an earlier report about a [Pd8L16]16+ cage by Fujita. They had obtained spectroscopic evidence (NMR, MS) for such an octanuclear cage during the synthesis of a dodecanuclear [Pd12L24]24+ cage.24 However, the octanuclear cage rearranged into the thermodynamically more stable dodecanuclear cage upon gentle heating (60 °C, 1 h).

In contrast, no post-synthetic rearrangement was observed for the cages based on C2. Selective precipitation of [Pd6(L2)12]12+ cage was achieved by adding ethyl acetate to the reaction mixture. After two cycles of precipitation, [Pd6(L2)12]12+ accounted for only 10% of the mixture, the rest being [Pd8(L2)16]16+ and [Pd9(L2)18]18+ in equal amounts. The high kinetic stability of the latter cages is illustrated by the fact that the composition of the mixture was not affected by heating for 20 h at 80 °C (Fig. S25).

While we were not able to isolate [Pd8L16]16+ on a preparative scale, we could grow crystals of this cage by slow vapor diffusion of diisopropyl ether into the [Pd6(L2)12]12+-depleted solution in nitromethane. A crystallographic analysis revealed a square antiprismatic geometry for [Pd8(L2)16]16+ (Fig. 9), as predicted theoretically.24 Unfortunately, BF4 anions and co-crystallized solvent molecules could not be localized (see the SI for details about the data treatment). However, the connectivity could clearly be established, with a maximum Pd⋯Pd distance of 20.2(2) Å.


image file: d5dt02223a-f9.tif
Fig. 9 Two views of the molecular structure of [Pd8(L2)16]16+, as determined by single-crystal XRD. The BF4 anions were not located and hydrogen atoms are not shown. Color coding: Pd dark green, C grey, N blue.

Until recently, square antiprismatic cages of type [Pd8L16]16+ had not been characterized crystallographically. While our work was in progress, a report by Pilgrim appeared, describing the structure of a [Pd8L16]16+ cage based on a bis-imidazole donor ligand with a perfluorobiphenyl linker.25 The presence of fluorine atoms on the biphenyl spacer was found to be crucial for the synthesis of this octanuclear assembly.

Conclusions

The stability of cages based on [Pd(N-donor)4]2+ links is a key factor for their potential applications. However, current knowledge of the relative stability of Pd-based cages remains limited, with most prior studies focusing on simple dinuclear systems. In this work, we examined the stability of eight hexanuclear cages of the type [Pd6L12]12+ or [Pd6L8]12+. Our results reveal substantial differences in the stability of the cages. The thermodynamic stability varies by almost two orders of magnitude, while kinetic stability spans over four orders of magnitude. The primary determinant influencing cage stability is the nature of the donor group, with denticity having a lesser effect. The use of imidazole-based ligands, which impart high kinetic stability, enabled access to a rare octanuclear cage, [Pd8(L2)16]16+, characterized by a square antiprismatic geometry.

Author contributions

J. d. M. performed the experiments and analyzed the data, F. F.-T. collected and processed the X-ray data, and J. d. M. and K. S. co-wrote the manuscript. All authors discussed the results and commented on the manuscript.

Conflicts of interest

There are no conflicts to declare.

Data availability

The data supporting this article have been included as part of the supplementary information (SI). Supplementary information: synthetic procedures and experimental details. See DOI: https://doi.org/10.1039/d5dt02223a.

CCDC 2487791 (C1), 2487789 (C3), 2487790 (C7) and 2487788 ([Pd8(L2)16](BF4)16) contain the supplementary crystallographic data for this paper.26a–d

Acknowledgements

The work was supported by the école Polytechnique Fédérale de Lausanne (EPFL). We thank Dr D. Ortiz (EPFL) for MS analyses, P. Gorrea-Acín (EPFL) for the synthesis of ligand L2 and Dr R.-J. Li (EPFL) for providing L6.

References

  1. (a) C. J. T. Cox, J. Hale, P. Molinska and J. E. M. Lewis, Chem. Soc. Rev., 2024, 53, 10380–10408 RSC; (b) T. Tateishi, M. Yoshimura, S. Tokuda, F. Matsuda, D. Fujita and S. Furukawa, Coord. Chem. Rev., 2022, 467, 214612 CrossRef CAS; (c) J. E. M. Lewis, Chem. Commun., 2022, 58, 13873–13886 RSC; (d) N. B. Debata, D. Tripathy and H. S. Sahoo, Coord. Chem. Rev., 2019, 387, 273–298 CrossRef CAS; (e) K. Harris, D. Fujita and M. Fujita, Chem. Commun., 2013, 49, 6703–6712 RSC.
  2. M. Han, D. M. Engelhard and G. H. Clever, Chem. Soc. Rev., 2014, 43, 1848–1860 RSC.
  3. D. Fujita, Y. Ueda, S. Sato, N. Mizuno, T. Kumasaka and M. Fujita, Nature, 2016, 540, 563–566 CrossRef CAS PubMed.
  4. M. Frank, M. D. Johnstone and G. H. Clever, Chem. – Eur. J., 2016, 22, 14104–14125 CrossRef CAS PubMed.
  5. (a) L. Neukirch and G. H. Clever, Chem. Sci., 2025, 16, 12242–12276 RSC; (b) Z. T. Avery, J. L. Algar and D. Preston, Trends Chem., 2024, 6, 352–364 CrossRef; (c) C.-B. Tian and Q.-F. Sun, Chem. – Eur. J., 2023, 29, e202300195 CrossRef CAS; (d) S. Pullen, J. Tessarolo and G. H. Clever, Chem. Sci., 2021, 12, 7269–7293 RSC; D. Bardhan and D. K. Chand, Chem. – Eur. J., 2019, 25, 12241–12269 Search PubMed.
  6. S. Saha, I. Regeni and G. H. Clever, Coord. Chem. Rev., 2018, 374, 1–14 CrossRef CAS.
  7. For reviews about application in catalysis, see: (a) Z. Ashbridge and J. N. H. Reek, Nat. Synth., 2024, 3, 1197–1207 CrossRef CAS; (b) T. K. Piskorz, V. Marti-Centelles, R. L. Spicer, F. Duarte and P. J. Lusby, Chem. Sci., 2023, 14, 11300–11331 RSC; (c) M. Otte, Eur. J. Org. Chem., 2023, e202300012 CrossRef CAS; (d) A. C. Pearcy and J. D. Crowley, Chem. – Eur. J., 2023, 29, e202203752 CrossRef CAS PubMed; (e) R. Saha, B. Mondal and P. S. Mukherjee, Chem. Rev., 2022, 122, 12244–12307 CrossRef CAS PubMed; (f) Y. Xue, X. Hang, J. Ding, B. Li, R. Zhu, H. Pang and Q. Xu, Coord. Chem. Rev., 2021, 430, 213656 CrossRef CAS; (g) A. B. Grommet, M. Feller and R. Klajn, Nat. Nanotechnol., 2020, 15, 256–271 CrossRef CAS PubMed.
  8. For reviews about applications in medicinal chemistry, see: (a) G. Moreno-Alcántar, M. Drexler and A. Casini, Nat. Rev. Chem., 2024, 8, 893–914 CrossRef PubMed; (b) G. Moreno-Alcántar and A. Casini, FEBS Lett., 2023, 597, 191–202 CrossRef.
  9. For reviews about cages with interesting photophysical properties, see: (a) E. Benchimol, J. Tessarolo and G. H. Clever, Nat. Chem., 2024, 16, 13–21 CrossRef CAS PubMed; (b) R. Ham, C. J. Nielsen, S. Pullen and J. N. H. Reek, Chem. Rev., 2023, 123, 5525–5261 CrossRef PubMed; (c) A. Brzechwa-Chodzyńska, W. Drożdż, J. Harrowfield and A. R. Stefankiewicz, Coord. Chem. Rev., 2021, 434, 213820 CrossRef; (d) H.-Y. Lin, L.-Y. Zhou and L. Xu, Chem. – Asian J., 2021, 16, 3805–3816 CrossRef CAS PubMed.
  10. For recent examples, see: (a) C. Hu, D. W. Chen, S. Sudan and K. Severin, Chem. Sci., 2025, 16, 5559–5564 RSC; (b) S. Bera, A. Dutta and P. Dastidar, Chem. – Asian J., 2024, 19, e202400419 CrossRef CAS PubMed; (c) D. J. Lundberg, C. M. Brown, E. O. Bobylev, N. J. Oldenhuis, Y. S. Alfaraj, J. Zhao, I. Kevlishvili, H. J. Kulik and J. A. Johnson, Nat. Commun., 2024, 15, 3951 CrossRef CAS PubMed; (d) C. Hu and K. Severin, Angew. Chem., Int. Ed., 2024, 63, e202403834 CrossRef CAS; (e) J. Zhao, E. O. Bobylev, D. J. Lundberg, N. J. Oldenhuis, H. Wang, I. Kevlishvili, S. L. Craig, H. J. Kulik, X. Li and J. A. Johnson, J. Am. Chem. Soc., 2023, 145, 21879–21885 CrossRef CAS PubMed.
  11. (a) M. Drexler, I. Kanavos, D. Krauss, G. Moreno-Alcántar, L. M. Smith, M. E. George, T. H. Witney, R. Lobinski, L. Rong and A. Casini, Inorg. Chem. Front., 2025 10.1039/D5QI01092F; (b) R. A. S. Vasdev, L. F. Gaudin, D. Preston, J. P. Jogy, G. I. Giles and J. D. Crowley, Front. Chem., 2018, 6, 563 CrossRef CAS PubMed; (c) D. Preston, S. M. McNeill, J. E. M. Lewis, G. I. Giles and J. D. Crowley, Dalton Trans., 2016, 45, 8050–8060 RSC; (d) S. M. McNeill, D. Preston, J. E. M. Lewis, A. Robert, K. Knerr-Rupp, D. O. Graham, J. R. Wright, G. I. Giles and J. D. Crowley, Dalton Trans., 2015, 44, 11129–11136 RSC; (e) D. Preston, A. Fox-Charles, W. K. C. Lo and J. D. Crowley, Chem. Commun., 2015, 43, 9042–9045 RSC; (f) J. E. M. Lewis, E. L. Gavey, S. A. Cameron and J. D. Crowley, Chem. Sci., 2012, 3, 778–784 RSC.
  12. G. Montà-González, D. Bastante-Rodríguez, A. Garcia-Farnández, P. J. Lusby, R. Martínez-Máñez and V. Martí-Centelles, Chem. Sci., 2024, 15, 10010–10017 RSC.
  13. X.-Z. Wang, D. W. Chen, F. Fadaei-Tirani, X.-P. Zhou and K. Severin, Angew. Chem., Int. Ed., 2025, 64, e202504880 CrossRef CAS PubMed.
  14. (a) B. Aikman, R. Bonsignore, B. Woods, D. Doellerer, R. Scotti, C. Schmidt, A. A. Heidecker, A. Pöthig, E. J. Sayers, A. T. Jones and A. Casini, Dalton Trans., 2022, 51, 7476–7490 RSC; (b) B. Woods, D. Döllerer, B. Aikman, M. N. Wenzel, E. Sayers, F. E. Kühn, A. Jones and A. Casini, J. Inorg. Biochem., 2019, 199, 110781 CrossRef CAS PubMed; (c) A. Ahmedova, R. Mihaylova, D. Momekova, P. Shestakova, S. Stoykova, J. Zaharieva, M. Yamashina, G. Momekov, M. Akita and M. Yoshizawa, Dalton Trans., 2016, 45, 13214–13221 RSC.
  15. (a) R.-J. Li, C. Pezzato, C. Berton and K. Severin, Chem. Sci., 2021, 12, 4981–4984 RSC; (b) S. M. Jansze and K. Severin, J. Am. Chem. Soc., 2019, 141, 815–819 CrossRef CAS PubMed; (c) S. M. Jansze, G. Cecot and K. Severin, Chem. Sci., 2018, 9, 4253–4257 RSC.
  16. H. V. Huynh, Chem. Lett., 2021, 50, 1831–1841 CrossRef CAS.
  17. D. Samanta and P. S. Mukherjee, Chem. – Eur. J., 2014, 20, 12483–12492 CrossRef CAS PubMed.
  18. (a) V. Sivalingam, M. Parbin, S. Krishnaswamy and D. K. Chand, Angew. Chem., Int. Ed., 2024, 63, 2303403711 Search PubMed; (b) A. C. Pearcy, L. S. Lisboa, D. Preston, N. B. Page, T. Lawrence, L. J. Wright, C. C. Hartinger and J. D. Crowely, Chem. Sci., 2023, 14, 8615–8623 RSC; (c) L. S. Lisboa, J. A. Findlay, L. J. Wright, C. G. Hartinger and J. D. Crowley, Angew. Chem., Int. Ed., 2020, 59, 11101–11107 CrossRef CAS PubMed; (d) S. Ganta and D. K. Chand, Inorg. Chem., 2018, 57, 3624–3645 Search PubMed; (e) J. J. Henkelis, J. Fisher, S. L. Warriner and M. J. Hardie, Chem. – Eur. J., 2014, 20, 4117–4125 CrossRef CAS PubMed.
  19. T. Y. Kim, L. Digal, M. G. Gardiner, N. T. Lucas and J. D. Crowley, Chem. – Eur. J., 2017, 23, 15089–15097 CrossRef CAS PubMed.
  20. K. C. Naik, S. J. Panda, A. K. Sutar and H. S. Sahoo, Inorg. Chem. Commun., 2023, 158, 111468 CrossRef CAS.
  21. B. Roy, R. Saha, A. K. Ghosh, Y. Patil and P. S. Mukherjee, Inorg. Chem., 2017, 56, 3579–3588 CrossRef CAS PubMed.
  22. J. de Montmollin, A. B. Solea, D. W. Chen, F. Fadaei-Tirani and K. Severin, Inorg. Chem., 2024, 63, 4583–4588 CrossRef CAS PubMed.
  23. R.-J. Li, A. Marcus, F. Fadaei-Tirani and K. Severin, Chem. Commun., 2021, 57, 10023–10026 RSC.
  24. D. Fujita, H. Yokoyama, Y. Ueda, S. Sato and M. Fujita, Angew. Chem., Int. Ed., 2015, 54, 155–158 CrossRef CAS PubMed.
  25. S. Bhattacharyya, S. P. Argent and B. S. Pilgrim, J. Am. Chem. Soc., 2025, 147, 30296–30303 CrossRef CAS PubMed.
  26. (a) CCDC 2487791: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2phrb9; (b) CCDC 2487789: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2phr87; (c) CCDC 2487790: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2phr98; (d) CCDC 2487788: Experimental Crystal Structure Determination, 2025,  DOI:10.5517/ccdc.csd.cc2phr76.

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.